Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2026-02-03 @ 8:09 AM
Study NCT ID:
NCT03997968
Status:
COMPLETED
Last Update Posted:
2024-12-24
First Post:
2019-06-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Sponsor:
Cyteir Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Malignancy | View |
| None | Non-hodgkin Lymphoma | View |
| None | Multiple Myeloma | View |
| None | Breast Cancer | View |
| None | Ovarian Cancer | View |
| None | Soft Tissue Sarcoma | View |
| None | Head and Neck Cancer | View |
| None | DLBCL | View |
| None | Mantle Cell Lymphoma | View |
| None | Follicular Lymphoma | View |
| None | Pancreatic Cancer | View |
| None | CLL | View |
| None | Small Cell Lung Cancer | View |
| None | Squamous Cell Carcinoma of Head and Neck | View |
| None | Triple Negative Breast Cancer | View |